Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
188
-
Total shares
-
74.7M
-
Shares change
-
+6.68M
-
Total reported value, excl. options
-
$1.24B
-
Value change
-
+$90.9M
-
Put/Call ratio
-
0.2
-
Number of buys
-
103
-
Number of sells
-
-85
-
Price
-
$16.65
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q4 2017
192 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q4 2017.
IMPAX LABORATORIES INC - COM (IPXL) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.7M shares
.
Largest 10 shareholders include BlackRock Inc. (9.84M shares), MAVERICK CAPITAL LTD (7.33M shares), Vanguard Group Inc (7.04M shares), WELLINGTON MANAGEMENT GROUP LLP (4.14M shares), Fosun International Ltd (3.85M shares), AMERIPRISE FINANCIAL INC (3.25M shares), DIMENSIONAL FUND ADVISORS LP (2.98M shares), STATE STREET CORP (2.51M shares), TCW GROUP INC (1.99M shares), and Invesco Ltd. (1.89M shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.